Guinea vs North Macedonia: Previously treated cases tested for RR-/MDR-TB
Guinea
29.0%
in 2024
North Macedonia
29.0%
in 2024
Guinea rank
161st
North Macedonia rank
161st
Previously treated cases tested for RR-/MDR-TB over time
- Guinea
- North Macedonia
How they compare
Guinea currently reports 29.0% against 29.0% in North Macedonia, a difference of 0.0%.
The two have swapped places 2 times across 19 shared years of data; in 2005 it was North Macedonia ahead.
Guinea ranks 161st and North Macedonia ranks 161st of 180 countries.
North Macedonia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Guinea | North Macedonia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.9% | 33.2% | 27.3% | North Macedonia |
| 2010s | 45.9% | 70.4% | 24.6% | North Macedonia |
| 2020s | 70.8% | 77.4% | 6.6% | North Macedonia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Guinea or North Macedonia?
- Guinea, at 29.0% against 29.0% in North Macedonia as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Guinea and North Macedonia?
- 0.0%, with Guinea ahead.
- How many years of comparable data are there for Guinea and North Macedonia?
- 19 years are reported by both, from 2005 to 2024.
- How do Guinea and North Macedonia rank globally for previously treated cases tested for rr-/mdr-tb?
- Guinea ranks 161st and North Macedonia ranks 161st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.